BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29940172)

  • 1. Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.
    Blasco-Benito S; Seijo-Vila M; Caro-Villalobos M; Tundidor I; Andradas C; García-Taboada E; Wade J; Smith S; Guzmán M; Pérez-Gómez E; Gordon M; Sánchez C
    Biochem Pharmacol; 2018 Nov; 157():285-293. PubMed ID: 29940172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of HER2-CB
    Blasco-Benito S; Moreno E; Seijo-Vila M; Tundidor I; Andradas C; Caffarel MM; Caro-Villalobos M; Urigüen L; Diez-Alarcia R; Moreno-Bueno G; Hernández L; Manso L; Homar-Ruano P; McCormick PJ; Bibic L; Bernadó-Morales C; Arribas J; Canals M; Casadó V; Canela EI; Guzmán M; Pérez-Gómez E; Sánchez C
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3863-3872. PubMed ID: 30733293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
    López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
    Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future Aspects for Cannabinoids in Breast Cancer Therapy.
    Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
    McAllister SD; Soroceanu L; Desprez PY
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of cannabinoids.
    Grotenhermen F
    Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights.
    Bimonte S; Palma G; Cascella M; Cuomo A
    Anticancer Res; 2023 Mar; 43(3):993-1000. PubMed ID: 36854495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
    López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
    Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects.
    Anand U; Pacchetti B; Anand P; Sodergren MH
    Pain Manag; 2021 Apr; 11(4):395-403. PubMed ID: 33703917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the Therapeutic Antitumor Potential of Cannabinoids.
    Bogdanović V; Mrdjanović J; Borišev I
    J Altern Complement Med; 2017 Nov; 23(11):831-836. PubMed ID: 28799775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cannabis an effective treatment for joint pain?
    Miller RJ; Miller RE
    Clin Exp Rheumatol; 2017; 35 Suppl 107(5):59-67. PubMed ID: 28967368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
    Fischedick J; Van Der Kooy F; Verpoorte R
    Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression and treatment of HER2-positive breast cancer.
    Davoli A; Hocevar BA; Brown TL
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):611-23. PubMed ID: 20087739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.